{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:46:00Z","timestamp":1792820760316,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-24157-2","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T07:41:39Z","timestamp":1755330099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of an optimized care model for advanced HIV disease: a non-randomized cluster study in Malawi"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5164-8913","authenticated-orcid":false,"given":"Thulani","family":"Maphosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Denoeud-Ndam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Chilikutali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddie","family":"Matiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilaal","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Nyirenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Mayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhoderick","family":"Machekano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Appolinaire","family":"Tiam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"key":"24157_CR1","first-page":"204993612412519","volume":"11","author":"B Ainembabazi","year":"2024","unstructured":"Ainembabazi B, Katana E, Bongomin F, Wanduru P, Mayega RW, Mukose AD. Prevalence of advanced HIV disease and associated factors among antiretroviral therapy Naive adults enrolling in care at public health facilities in kampala, Uganda. Ther Adv Infect Dis. 2024;11:20499361241251936.","journal-title":"Ther Adv Infect Dis"},{"issue":"3","key":"24157_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1056\/NEJMe1707598","volume":"377","author":"N Ford","year":"2017","unstructured":"Ford N, Doherty M. The enduring challenge of advanced HIV infection. N Engl J Med. 2017;377(3):283\u20134.","journal-title":"N Engl J Med"},{"key":"24157_CR3","doi-asserted-by":"publisher","first-page":"232595822312219","DOI":"10.1177\/23259582231221955","volume":"22","author":"ON Chabikuli","year":"2023","unstructured":"Chabikuli ON, Ditekemena JD, Sigwadhi LN, Mulenga A, Mboyo A, Bidashimwa D, et al. Advanced HIV disease at antiretroviral therapy initiation and treatment outcomes among children and adolescents compared to adults living with HIV in kinshasa, Democratic Republic of the congo. J Int Assoc Provid AIDS Care. 2023;22:23259582231221955.","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"24157_CR4","doi-asserted-by":"publisher","unstructured":"Baldeh M, Kizito S, Lakoh S, Sesay D, Dennis F, Barrie U, et al. Prevalence and factors associated with advanced HIV disease among young people aged 15\u201324 years in a national referral hospital in Sierra Leone: A cross-sectional study [Preprint]. medRxiv. 2023. https:\/\/doi.org\/10.1101\/2023.11.07.23296880.","DOI":"10.1101\/2023.11.07.23296880"},{"issue":"12","key":"24157_CR5","doi-asserted-by":"publisher","first-page":"e70285","DOI":"10.1002\/hsr2.70285","volume":"7","author":"S Haumba","year":"2024","unstructured":"Haumba S, Arora S, Williams V, Maseko T, Mafukidze A, Ojoo S. Prevalence, predictors, and outcomes of HIV care in HIV-Positive clients entering HIV care with advanced HIV disease in Sub-Saharan Africa 2010\u20132022: systematic review and Meta-Analysis. Health Sci Rep. 2024;7(12):e70285.","journal-title":"Health Sci Rep"},{"issue":"1","key":"24157_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12981-020-00296-x","volume":"17","author":"AT Boyd","year":"2020","unstructured":"Boyd AT, Oboho I, Paulin H, Ali H, Godfrey C, Date A, et al. Addressing advanced HIV disease and mortality in global HIV programming. AIDS Res Ther. 2020;17(1):40.","journal-title":"AIDS Res Ther"},{"issue":"1","key":"24157_CR7","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1186\/s12889-023-17384-y","volume":"23","author":"L Katirayi","year":"2023","unstructured":"Katirayi L, Maphosa T, Chilikutali L, Chamanga RK, Petersson J, Khatib S, et al. Understanding gender differences of people with HIV newly diagnosed or returning to care with advanced HIV disease in Malawi: a qualitative study. BMC Public Health. 2023;23(1):2382.","journal-title":"BMC Public Health"},{"issue":"1","key":"24157_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12913-024-10700-1","volume":"24","author":"T Maphosa","year":"2024","unstructured":"Maphosa T, Denoeud-Ndam L, Kapanda L, Khatib S, Chilikutali L, Matiya E, et al. Understanding health systems challenges in providing advanced HIV disease (AHD) care in a hub and spoke model: a qualitative analysis to improve AHD care program in Malawi. BMC Health Serv Res. 2024;24(1):244.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"24157_CR9","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1186\/s12879-024-09682-6","volume":"24","author":"SA Sakyi","year":"2024","unstructured":"Sakyi SA, Kwarteng S, Senu E, Effah A, Opoku S, Oppong SA, et al. High prevalence of late presentation with advanced HIV disease and its predictors among newly diagnosed patients in Kumasi, Ghana. BMC Infect Dis. 2024;24(1):764.","journal-title":"BMC Infect Dis"},{"key":"24157_CR10","first-page":"313","volume":"16","author":"A Bendera","year":"2024","unstructured":"Bendera A, Baryomuntebe DM, Kevin NU, Nanyingi M, Kinengyere PB, Mujeeb S, et al. Determinants of late HIV diagnosis and advanced HIV disease among people living with HIV in Tanzania. HIV AIDS (Auckl). 2024;16:313\u201323.","journal-title":"HIV AIDS (Auckl)"},{"key":"24157_CR11","unstructured":"WHO. Identifying common opportunistic infections among people with advanced HIV disease. 2023."},{"key":"24157_CR12","first-page":"7075601","volume":"2017","author":"DW Gunda","year":"2017","unstructured":"Gunda DW, Nkandala I, Kilonzo SB, Kilangi BB, Mpondo BC. Prevalence and risk factors of mortality among adult HIV patients initiating ART in rural setting of HIV care and treatment services in North Western tanzania: A retrospective cohort study. J Sex Transm Dis. 2017;2017:7075601.","journal-title":"J Sex Transm Dis"},{"issue":"1","key":"24157_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12879-024-09112-7","volume":"24","author":"D Owachi","year":"2024","unstructured":"Owachi D, Akatukunda P, Nanyanzi DS, Katwesigye R, Wanyina S, Muddu M, et al. Mortality and associated factors among people living with HIV admitted at a tertiary-care hospital in Uganda: a cross-sectional study. BMC Infect Dis. 2024;24(1):239.","journal-title":"BMC Infect Dis"},{"issue":"Suppl 5","key":"24157_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25778","volume":"24","author":"J Stover","year":"2021","unstructured":"Stover J, Glaubius R, Kassanjee R, Dugdale CM. Updates to the spectrum\/aim model for the UNAIDS 2020 HIV estimates. J Int AIDS Soc. 2021;24(Suppl 5): e25778.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"24157_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-21153-z","volume":"12","author":"E Nacarapa","year":"2022","unstructured":"Nacarapa E, Munyangaju I, Osorio D, Zindoga P, Mutaquiha C, Jose B, et al. Extrapulmonary tuberculosis mortality according to clinical and point of care ultrasound features in Mozambique. Sci Rep. 2022;12(1): 16675.","journal-title":"Sci Rep"},{"issue":"3","key":"24157_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.7196\/SAMJ.2022.v112i3.16193","volume":"112","author":"D Osorio","year":"2022","unstructured":"Osorio D, Munyangaju I, Nacarapa E, Nhangave AV, Ramos-Rincon JM. Predictors of unfavourable tuberculosis treatment outcome in bilene district, Gaza province, mozambique: A retrospective analysis, 2016\u20132019. S Afr Med J. 2022;112(3):234\u20139.","journal-title":"S Afr Med J"},{"issue":"12","key":"24157_CR17","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1097\/QAD.0000000000002971","volume":"35","author":"TA Makadzange","year":"2021","unstructured":"Makadzange TA, Hlupeni A, Machekano R, Boyd K, Mtisi T, Nyamayaro P, et al. Survival following screening and preemptive antifungal therapy for subclinical Cryptococcal disease in advanced HIV infection. AIDS. 2021;35(12):1929\u201338.","journal-title":"AIDS"},{"issue":"8","key":"24157_CR18","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1093\/cid\/ciz485","volume":"70","author":"RM Wake","year":"2020","unstructured":"Wake RM, Govender NP, Omar T, Nel C, Mazanderani AH, Karat AS, et al. Cryptococcal-related mortality despite fluconazole preemptive treatment in a Cryptococcal antigen screen-and-treat program. Clin Infect Dis. 2020;70(8):1683\u201390.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"24157_CR19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12879-022-07224-6","volume":"22","author":"C Kanyama","year":"2022","unstructured":"Kanyama C, Chagomerana MB, Chawinga C, Ngoma J, Shumba I, Kumwenda W, et al. Implementation of tuberculosis and Cryptococcal meningitis rapid diagnostic tests amongst patients with advanced HIV at Kamuzu central hospital, malawi, 2016\u20132017. BMC Infect Dis. 2022;22(1):224.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"24157_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/cid\/civ936","volume":"62","author":"N Longley","year":"2016","unstructured":"Longley N, Jarvis JN, Meintjes G, Boulle A, Cross A, Kelly N, et al. Cryptococcal antigen screening in patients initiating ART in South Africa: a prospective cohort study. Clin Infect Dis. 2016;62(5):581\u20137.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"24157_CR21","doi-asserted-by":"publisher","first-page":"17897","DOI":"10.1038\/s41598-021-97466-2","volume":"11","author":"E Nacarapa","year":"2021","unstructured":"Nacarapa E, Verdu ME, Nacarapa J, Macuacua A, Chongo B, Osorio D, et al. Predictors of attrition among adults in a rural HIV clinic in Southern Mozambique: 18-year retrospective study. Sci Rep. 2021;11(1):17897.","journal-title":"Sci Rep"},{"key":"24157_CR22","unstructured":"World Health Organization. (2020, July). Technical brief: Package of care for children and adolescents with advanced HIV disease: STOP AIDS. World Health Organization. https:\/\/www.who.int\/publications\/i\/item\/9789240011553"},{"issue":"8","key":"24157_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25774","volume":"24","author":"WT Steward","year":"2021","unstructured":"Steward WT, Agnew E, de Kadt J, Ratlhagana MJ, Sumitani J, Gilmore HJ, et al. Impact of SMS and peer navigation on retention in HIV care among adults in South Africa: results of a three-arm cluster randomized controlled trial. J Int AIDS Soc. 2021;24(8): e25774.","journal-title":"J Int AIDS Soc"},{"issue":"7","key":"24157_CR24","doi-asserted-by":"publisher","first-page":"e1002874","DOI":"10.1371\/journal.pmed.1002874","volume":"16","author":"MP Fox","year":"2019","unstructured":"Fox MP, Pascoe S, Huber AN, Murphy J, Phokojoe M, Gorgens M, et al. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa. PLoS Med. 2019;16(7):e1002874.","journal-title":"PLoS Med"},{"key":"24157_CR25","doi-asserted-by":"publisher","unstructured":"Burke, R. M., Nyirenda, S. K., Mtenga, T., Twabi, H. H., Joekes, E., Walker, N. F., et al. (2024). Enhanced tuberculosis diagnosis with computer-aided chest X-ray and urine LAM in adults with HIV admitted to hospital (CASTLE study): A cluster randomised trial. Clinical Infectious Diseases. https:\/\/doi.org\/10.1093\/cid\/ciae066","DOI":"10.1093\/cid\/ciae066"},{"issue":"1","key":"24157_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12981-023-00581-5","volume":"20","author":"TC Scheier","year":"2023","unstructured":"Scheier TC, Youssouf N, Mosepele M, Kanyama C, Adekanmbi O, Lakoh S, et al. Standard of care in advanced HIV disease: review of HIV treatment guidelines in six sub-Saharan African countries. AIDS Res Ther. 2023;20(1):83.","journal-title":"AIDS Res Ther"},{"key":"24157_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2334-12-103","volume":"12","author":"SD Lawn","year":"2012","unstructured":"Lawn SD. Point-of-care detection of Lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infect Dis. 2012;12:103.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"24157_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/QAI.0b013e318258c6af","volume":"60","author":"SD Lawn","year":"2012","unstructured":"Lawn SD, Kerkhoff AD, Vogt M, Wood R. High diagnostic yield of tuberculosis from screening urine samples from HIV-infected patients with advanced immunodeficiency using the Xpert MTB\/RIF assay. J Acquir Immune Defic Syndr. 2012;60(3):289\u201394.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"24157_CR29","doi-asserted-by":"publisher","first-page":"701","DOI":"10.5588\/ijtld.12.0131","volume":"16","author":"SD Lawn","year":"2012","unstructured":"Lawn SD, Kerkhoff AD, Wood R. Location of Xpert(R) MTB\/RIF in centralised laboratories in South Africa undermines potential impact. Int J Tuberc Lung Dis. 2012;16(5):701. author reply 2.","journal-title":"Int J Tuberc Lung Dis"},{"key":"24157_CR30","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01238-18","author":"R Rajasingham","year":"2019","unstructured":"Rajasingham R, Wake RM, Beyene T, Katende A, Letang E, Boulware DR. Cryptococcal meningitis diagnostics and screening in the era of point-of-care laboratory testing. J Clin Microbiol. 2019. https:\/\/doi.org\/10.1128\/JCM.01238-18.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"24157_CR31","doi-asserted-by":"publisher","first-page":"e0292660","DOI":"10.1371\/journal.pone.0292660","volume":"18","author":"A Tiam","year":"2023","unstructured":"Tiam A, Paulin H, Machekano R, Oboho I, Agyemang E, Mugyenyi FA, et al. Rapid antiretroviral therapy initiation in patients with advanced HIV disease: 6-month outcomes of an observational cohort evaluation in Lesotho. PLoS One. 2023;18(10):e0292660.","journal-title":"PLoS One"},{"issue":"8","key":"24157_CR32","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/hiv.13487","volume":"24","author":"A Lehman","year":"2023","unstructured":"Lehman A, Ellis J, Nalintya E, Bahr NC, Loyse A, Rajasingham R. Advanced HIV disease: a review of diagnostic and prophylactic strategies. HIV Med. 2023;24(8):859\u201376.","journal-title":"HIV Med"},{"key":"24157_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.12688\/wellcomeopenres.19324.1","volume":"9","author":"J Ellis","year":"2024","unstructured":"Ellis J, Nsangi L, Bangdiwala A, Hale G, Gakuru J, Kagimu E, et al. Integrated management of Cryptococcal meningitis and concurrent opportunistic infections to improve outcomes in advanced HIV disease: a randomised strategy trial. Wellcome Open Res. 2024;9:14.","journal-title":"Wellcome Open Res"},{"issue":"1","key":"24157_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5588\/ijtldopen.23.0194","volume":"1","author":"L Gunde","year":"2024","unstructured":"Gunde L, Wang A, Payne D, O\u2019Connor S, Kabaghe A, Kalata N, et al. Characteristics of TPT initiation and completion among people living with HIV. IJTLD Open. 2024;1(1):11\u20139.","journal-title":"IJTLD Open"},{"key":"24157_CR35","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6113.1000488","author":"FJ Louis","year":"2015","unstructured":"Louis FJ, Osborne AJ, Elias VJ, Buteau J, Boncy J, Elong A, et al. Specimen referral network to rapidly scale-Up CD4 testing: the hub and spoke model for Haiti. J AIDS Clin Res. 2015. https:\/\/doi.org\/10.4172\/2155-6113.1000488.","journal-title":"J AIDS Clin Res"},{"issue":"1","key":"24157_CR36","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/QAI.0000000000000547","volume":"69","author":"AF Auld","year":"2015","unstructured":"Auld AF, Kamiru H, Azih C, Baughman AL, Nuwagaba-Biribonwoha H, Ehrenkranz P, et al. Implementation and operational research: evaluation of swaziland\u2019s Hub-and-Spoke model for decentralizing access to antiretroviral therapy services. J Acquir Immune Defic Syndr. 2015;69(1):e1\u201312.","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24157-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-24157-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24157-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T14:53:55Z","timestamp":1757429635000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-24157-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24157"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-24157-2","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,16]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data collection was limited to secondary data abstraction of data that were routinely collected and documented as part of the AHD standard medical care of the project, without any direct interaction between the program evaluation staff and study participants. This study and all the procedures involved in collecting and analyzing routine program data imposed minimal risk to participants; therefore, the Institutional Review Boards granted a waiver of consent.Ethical clearance was obtained from the National Health Science Research Committee on 21\/06\/2720. The Advarra Institutional Review Board reviewed and approved the study on 6 October 2021 (protocol number Pro00057717). All study procedures were conducted in accordance with the ethical standards of the institutional and national research committees, as well as with the principles outlined in the Declaration of Helsinki and relevant national guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2802"}}